Anna Marie Davies

Title: Innovations of Anna Marie Davies in Anti-IgE Antibodies

Introduction

Anna Marie Davies is a prominent inventor based in London, GB. She has made significant contributions to the field of immunology, particularly in the development of anti-IgE antibodies. With a total of 2 patents, her work focuses on improving treatments for disorders caused by IgE, such as allergic and autoimmune responses.

Latest Patents

Her latest patents revolve around the area of improved anti-IgE antibodies and antigen binding agents. These inventions target IgE for use in treating disorders caused by its interaction with the FcεRI receptor. The improved anti-IgE antibodies may exhibit enhanced affinity for IgE and improved interactions with the Cε2 domain of IgE. Additionally, they may possess the ability to disassociate IgE from the FcεRI receptor at pharmaceutically relevant concentrations. This innovation aims to provide novel treatments for IgE-mediated disorders by effectively targeting free IgE and IgE complexed with the FcεRI receptor.

Career Highlights

Anna Marie Davies is currently associated with Ucbbiopharma Srl, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of IgE-related disorders.

Collaborations

Some of her notable coworkers include Ralph Adams and Thomas Allen Ceska, who have collaborated with her on various projects related to her patents.

Conclusion

Anna Marie Davies is a key figure in the field of immunology, with her innovative work on anti-IgE antibodies paving the way for improved treatments for allergic and autoimmune disorders. Her contributions are vital in enhancing the efficacy of therapies targeting IgE.